TITLE

Cytosponge screening for Barrett's oesophagus preferred

PUB. DATE
November 2012
SOURCE
PharmacoEconomics & Outcomes News;11/10/2012, Issue 666, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses research on cytosponge in screening for Barrett's oesophagus that references the study "Health Benefits and Cost-Effectiveness of Endoscopic and Non-Endoscopic Cytosponge Screening for Barrett's Esophagus," by T. Benaglia et al in the October 2012 issue of "Gastroenterology."
ACCESSION #
83632233

 

Related Articles

  • Guidelines confirm RFA for BE treatment.  // Medical Device Daily;3/11/2011, Vol. 15 Issue 48, p5 

    The article reports on the American Gastroenterological Association (AGA) Medical Position Statement on the Treatment of Barrett's Esophagus which recommends the removal of precancerous cells in patients with confirmed high-grade Barrett's esophagus using endoscopic eradication therapy like...

  • Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study. Ross-Innes, Caryn S.; Debiram-Beecham, Irene; O'Donovan, Maria; Walker, Elaine; Varghese, Sibu; Lao-Sirieix, Pierre; Lovat, Laurence; Griffin, Michael; Ragunath, Krish; Haidry, Rehan; Sami, Sarmed S.; Kaye, Philip; Novelli, Marco; Disep, Babett; Ostler, Richard; Aigret, Benoit; North, Bernard V.; Bhandari, Pradeep; Haycock, Adam; Morris, Danielle // PLoS Medicine;Jan2015, Vol. 12 Issue 1, p1 

    Background: Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocarcinoma. Routine endoscopic screening for BE is not recommended because of the burden this would impose on the health care system. The objective of this study was to determine whether...

  • Diagnosis and treatment of Barrett's oesophagus. Lim, Yean Cheant; Fitzgerald, Rebecca C. // British Medical Bulletin;Sep2013, Vol. 107 Issue 1, p117 

    Introduction Barrett's oesophagus (BO) is a common premalignant condition, which carries a risk of progression to oesophageal adenocarcinoma. Recent advances include quantifying the risk of neoplasia progression, novel diagnostic tools and development of new endoscopic techniques to treat early...

  • Editorial: Optimization and Expansion of Predictive Models for Barrett's Esophagus and Esophageal Adenocarcinoma: Could a Life-Course Exposure History Be Beneficial?? Cook, Michael B // American Journal of Gastroenterology;Jun2013, Vol. 108 Issue 6, p923 

    Thrift et al. provide preliminary evidence that younger age of symptomatic gastroesophageal reflux disease exposure is associated with increased risk of Barrett's esophagus. If these findings are confirmed in other studies, the next logical steps are to test whether this, and other age-specific...

  • Evaluating the clinical efficacy and cost effectiveness of direct access endoscopy. Broe, M.; Barry, M.; Patchett, S.; Hill, A.D.K. // Surgeon (Elsevier Science);Dec2013, Vol. 11 Issue 6, p304 

    Introduction Direct access endoscopy (DAE) allows primary care physicians (PCPs) to refer patients with concerning symptoms for endoscopy in a timely manner. Guidelines are available to assist PCPs in appropriately selecting patients for DAE. The objective of this study was to evaluate both the...

  • Cost-effective paradigm shift in Barrett's oesophagus?  // PharmacoEconomics & Outcomes News;12/12/2009, Issue 593, p6 

    The article discusses two studies on the treatment of Barrett's oesophagus. The first study concluded that radiofrequency ablation (RFA) is more cost effective than oesophagectomy in treating persistent high-grade dysplasia (HGD) in Barrett's oesophagus. The other study compared the cost...

  • Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett's Esophagus. Sharaiha, Reem; Freedberg, Daniel; Abrams, Julian; Wang, Y. // Digestive Diseases & Sciences;Jun2014, Vol. 59 Issue 6, p1222 

    Background: Proton pump inhibitors (PPIs) may reduce the risk of esophageal adenocarcinoma (EAC) in patients with Barrett's esophagus. PPIs are prescribed for virtually all patients with Barrett's esophagus, irrespective of the presence of reflux symptoms, and represent a de facto...

  • Acetic acid-enhanced chromoendoscopy is more cost-effective than protocol-guided biopsies in a high-risk Barrett's population. Bhandari, P.; Kandaswamy, P.; Cowlishaw, D.; Longcroft-Wheaton, G. // Diseases of the Esophagus;Jul2012, Vol. 25 Issue 5, p386 

    SUMMARY To examine the efficacy and potential cost implications of acetic acid (AA) chromoendoscopy in the assessment of Barrett's neoplasia. Our prospective database of patients referred between 2005 and 2010 with suspected early neoplasia was reviewed. High-resolution Fujinon gastroscopes and...

  • Should you reuse markers after designating site?  // Same-Day Surgery;Dec2008, Vol. 32 Issue 12, p127 

    The article offers information on the idea of reusing surgical markers after designating surgical sites as a cost effective measure for hospitals.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics